MedTech
25 Years of Guardtech: Compliance Manager Chris McGinn Q&A
One of the Group’s longest-serving stalwarts gives his take on why quality and compliance is so critical to keeping Guardtech at the apex of the industry’s cleanroom construction providers ...
The European health data space: Key features and opportunities for access and research
In a previous blog post, we briefly outlined the plans of the European Union (EU) to facilitate access to high-quality data for scientific research. Three main EU initiatives aim at enabling such access. The first initiative focusses on the establishment of a network of common Euro...
Privacy implications of secondary use of personal data for scientific research in the European Union
Scientific research is front and centre in innovation policies across Europe, and the European Union (EU)'s research agenda makes no exception. ...
UK Biobank: A case-study of biomedical research with Databanks and its privacy and data protection considerations
In a previous blog post, we outlined the typical privacy and data protection implications of conducting biomedical research using personal data from health databanks. These implications relate to the reliability of anonymisation, valid grounds for the reuse of health data, transparency ...
EFEC’s role in advancing UK-China life sciences collaboration at MTI Expo 2025
Excellence First Enterprise Consultancy Ltd (EFEC) continues to play a pivotal role in bridging the UK and China across education, talent, and innovation ecosystems, with a particular focus on life sciences and healthcare technology. At the 2025 UK Medical Technology Innovation Expo (MT...
Bradford Hill Seminar: The Cancer Loyalty Card Study (CLOCS), aiming to help reduce the delays in cancer diagnosis using transaction data
About this talk The first CLOCS project showed that ovarian cancer patients started buying over- the-counter medications up to 8 or 9 months before their diagnosis, with their first GP visit regarding their symptoms on average 3.5 months before diagnosis. This suggests that there is a w...
Cambridge NeuroWorks Fellows showcase innovation at connecting neuroscience workshop
Cambridge NeuroWorks Fellows had a brilliant opportunity to showcase their research at the Cambridge NeuroWorks Connecting Neuroscience event, held in collaboration with Cambridge Neuroscience and Cambridge Network. ...
Supporting our clients globally - Team Consulting welcomes David Maltz
As part of our continued international growth, Team Consulting is pleased to welcome David Maltz as the newest member of our commercial team. David joins Team as SVP – Business Development (US) with more than 15 years of experience in the medical device industry, where he has focused on...
Brain injury survivors help shape new medical technologies
Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors. ...
“Think like a car salesperson”: What biotech and AI start-ups can learn about selling
For many UK start-ups in biotech and AI, selling doesn’t come naturally. Founders are often scientists, engineers, developers or researchers, brilliant at building, but less comfortable with business. Yet, no matter how innovative your product is, it won’t make an impact unless someone ...